Belharra Therapeutics
PrivateLast Round
Series A
Jan 4, 2023
Total Funding Raised
$50M
Company Overview
Belharra Therapeutics is a biotechnology company that develops a photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously undruggable protein targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Belharra Therapeutics Comparables
Compare Belharra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BridGene Biosciences | 89% | |
| Nexo Therapeutics | 83% | |
| Frontier Medicines | 82% |
Belharra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 4, 2023 |
Belharra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 10, 2025
Sean Buchanan appointed as Chief Scientific Officer.
- Jan 4, 2023
$50M round led by Versant Ventures
Belharra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Belharra Therapeutics's valuation, stock price, and market status.
Is Belharra Therapeutics a public or private company?
Belharra Therapeutics is a private company.
What is the current stock price of Belharra Therapeutics?
Belharra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Belharra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Belharra Therapeutics worth (valuation)?
Valuation information for Belharra Therapeutics is not publicly available.
Can I buy Belharra Therapeutics stock?
Belharra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Belharra Therapeutics's last funding round?
Belharra Therapeutics's most recent funding round was Series A on January 4, 2023.
Who are the main investors in Belharra Therapeutics?
Key investors in Belharra Therapeutics include Versant Ventures.
Will Belharra Therapeutics IPO soon?
No public IPO plans have been announced for Belharra Therapeutics.
How can I track Belharra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Belharra Therapeutics's shares on secondary markets.